Sponsor Pipeline

Epicrispr Biotechnologies, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-21 NCT06907875
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy		 overall status: Recruiting → Active, Not Recruiting
2026-07-21 NCT06907875
A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy		 date change Primary completion moved earlier: 2031-03-31 -> 2027-07-07
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06907875 A First-in-human Study of EPI-321 in Facioscapulohumeral Muscular Dystrophy Facioscapulohumeral Muscular Dystrophy Active, Not Recruiting
Get alerts when Epicrispr Biotechnologies, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free